Trajan Group (TRJ) Stock Price, News & Analysis

Company Overview

Trajan Group Holdings Limited develops, manufactures, sells, and distributes analytical and life science products and devices in Australia, New Zealand, Malaysia, Japan, the United States, Europe, the Middle East, Africa, and India. The company offers analytical products, including syringes, GC columns and septa, rings, inlet liners, and tubing products; pathology products, consisting of NBF containers, adhesive and frosted microscope slides, coverslips, slide storage trays/mailers, cassette storage boxes, biopsy pads, histology wax plus, microtome blades, and marking dyes and sets, and MiPlatform, a smartphone adapter. It also provides sampling products, comprising septa, caps, liners, crimping tools, well plates and sealing mats, and micro sampling tools, as well as automation systems for the analysis of biological, food, and environmental samples. The company was incorporated in 2011 and is headquartered in Ringwood, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: $121.88 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: N/A
• Current Symbol: ASX:TRJ
• CIK: N/A
• Web: www.trajanscimed.com
• Phone: 61 3 9837 4200
• Fax: N/A
• Employees: 600
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): A($0.17)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-25,330,000.00
• Net Margins: -16.34%
• Pretax Margin: N/A
• Return on Equity: -22.21%
• Return on Assets: 0.08%

Debt

• Debt-to-Equity Ratio: 54.61
• Current Ratio: 0.86
• Quick Ratio: 0.42

Sales & Book Value

• Annual Sales: $155.02 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: A$0.68 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 152,260,000
• Free Float: N/A
• Market Cap: $121.88 million
• Optionable: Not Optionable
• Beta: 0.69